Alvotech (ALVO)
13.49
-0.01
(-0.07%)
USD |
NASDAQ |
May 17, 16:00
13.49
0.00 (0.00%)
After-Hours: 20:00
Alvotech Cash from Investing (Quarterly): -10.46M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.46M |
| September 30, 2023 | -10.65M |
| June 30, 2023 | -11.35M |
| March 31, 2023 | -13.88M |
| Date | Value |
|---|---|
| December 31, 2022 | -10.47M |
| September 30, 2022 | -11.56M |
| June 30, 2022 | -28.31M |
| March 31, 2022 | -13.19M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-28.31M
Minimum
Jun 2022
-10.46M
Maximum
Dec 2023
-13.73M
Average
-11.46M
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie Inc | -9.588B |
| Teva Pharmaceutical Industries Ltd | 144.00M |
| Moolec Science SA | -0.1281M |
| Procaps Group SA | -7.469M |
| NeuroMetrix Inc | 0.098M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -67.16M |
| Cash from Financing (Quarterly) | 20.66M |
| Free Cash Flow | -358.66M |
| Free Cash Flow Per Share (Quarterly) | -0.2909 |
| Free Cash Flow to Equity (Quarterly) | -125.71M |
| Free Cash Flow to Firm (Quarterly) | -16.23M |
| Free Cash Flow Yield | -11.20% |